Citations to this article


Hepatitis C-associated osteosclerosis (HCAO) is a rare disorder characterized by a marked increase in bone mass during adult life. Despite the rarity of HCAO, understanding the mediator(s) of the skeletal disease is of great interest. The IGFs-I and -II have potent anabolic effects on bone, and alterations in the IGFs and/or IGF-binding proteins (IGFBPs) could be responsible for the increase in bone formation in this disorder. Thus, we assayed sera from seven cases of HCAO for IGF-I, IGF-II, IGF-IIE (an IGF-II precursor), and IGFBPs. The distribution of the serum IGFs and IGFBPs between their ternary ( approximately 150 kD) and binary (approximately 50 kD) complexes was also determined to assess IGF bioavailability. HCAO patients had normal serum levels of IGF-I and -II, but had markedly elevated levels of IGF-IIE. Of the IGFBPs, an increase in IGFBP-2 was unique to these patients and was not found in control hepatitis C or hepatitis B patients. IGF-I and -II in sera from patients with HCAO were carried, as in the case of sera from control subjects, bound to IGFBP-3 in the approximately 150-kD complex, which is retained in the circulation. However, IGF-IIE was predominantly in the approximately 50-kD complex in association with IGFBP-2; this complex can cross the capillary barrier and access target tissues. In vitro, we found that IGF-II enhanced by over threefold IGFBP-2 binding to extracellular matrix produced by human osteoblasts and that in an extracellular matrix-rich environment, the IGF-II/IGFBP-2 complex was as effective as IGF-II alone in stimulating human osteoblast proliferation. Thus, IGFBP-2 may facilitate the targeting of IGFs, and in particular IGF-IIE, to skeletal tissue in HCAO patients, with a subsequent stimulation by IGFs of osteoblast function. Our findings in HCAO suggest a possible means to increase bone mass in patients with osteoporosis.


S Khosla ... R L Hintz, C A Conover


Total citations by year

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Total
Citations: 1 3 2 5 8 4 1 4 5 4 2 5 1 2 1 2 2 52
Citation information

Citations to this article in year 2006 (4)

Title and authors Publication Year
IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo
J Rubin, X Fan, J Rahnert, B Sen, C Hsieh, TC Murphy, MS Nanes, LG Horton, WG Beamer, CJ Rosen
The Prostate 2006
Analysis of Bone Mineral Density and Turnover in Patients with Cystic Fibrosis: Associations between the IGF System and Inflammatory Cytokines
ME Street, C Spaggiari, MA Ziveri, C Volta, G Federico, GI Baroncelli, S Bernasconi, G Saggese
Hormone Research 2006
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane
Dynamics of Bone and Cartilage Metabolism 2006
Os et foie
G Chal├Ęs, P Guggenbuhl
EMC - H├ępatologie 2006